Synergistic up-regulation of epithelial cell matrix metalloprotemase-9 secretion in tuberculosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 37, Issue 4, 2007, Pages 431-437

  Elkington, Paul T ^a   Green, Justin A ^a   Emerson, Jenny E ^a   Lopez Pascua, Laura D ^a   Boyle, Joseph J ^a   O'Kane, Cecilia M ^a   Friedland, Jon S ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Epithelial cell; Matrix metalloproteinase; Tuberculosis

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GELATIN; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CELL LINE; CULTURE MEDIUM; ENZYME RELEASE; EPITHELIUM CELL; GELATIN ZYMOGRAPHY; HOST PATHOGEN INTERACTION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; UPREGULATION; ZYMOGRAPHY;

BACTERIAL PROTEINS; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 9; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RESPIRATORY MUCOSA; RNA, MESSENGER; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 34848912309     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0011OC     Document Type: Article

References (50)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA 1999;282:677-686.
2. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.
3. Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M, Mathema B, Ramaswamy SV, Walther G. Steyn LM, et al. Mycobacterium tuberculosis growth at the cavity surface: A microenvironment with failed immunity. Infect Immun 2003;71:7099-7108.
4. Schluger NW. The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years. Am J Respir Cell Mol Biol 2005;32:251-256.
5. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004;22:599-623.
6. Orme IM. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol 1998;6:94-97.
7. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-alpha is required in the protective immune response against mycobacterium tuberculosis in mice. Immunity 1995;2:561-572.
8. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (i1-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med 1997;186:39-45.
9. Dunsmore SE, Rannels DE. Extracellular matrix biology in the lung. Am J Physiol 1996;270:L3-27.
10. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001;2:10-19.
11. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-629.
12. Lanone S, Zheng T, Zhu Z, Liu W, Lee CG, Ma B, Chen Q, Homer RJ, Wang J, Rabach LA, et al Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in i1-13-induced inflammation and remodeling. J Clin Invest 2002; 110:463-474.
13. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Fan Chung K. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers: regulation by interleukin-10. Am J Respir Crit Care Med 2000;162:1355-1360.
14. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002;26:602-609.
15. Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 2005;172:1378-1382.
16. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. Human 92- and 72-kilodalton type iv collagenases are elastases. J Biol Chem 1991;266:7870-7875.
17. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase b: a tuner and amplifier of immune functions. Trends Immunol 2001;22:571-579.
18. Price NM, Farrar J, Tran TT, Nguyen TH, Tran TH. Friedland JS. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J Immunol 2001;166:4223-4230.
19. Chang JC, Wysocki A, Tchou-Wong KM, Moskowitz N, Zhang Y, Rom WN. Effect of mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 1996;51:306-311.
20. Quiding-Jarbrink M, Smith DA, Bancroft GJ. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 2001;69:5661-5670.
21. Park KJ, Hwang SC, Sheen SS, Oh YJ, Han JH, Lee KB. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration (Herrlisheim) 2005;72:166-175.
22. Hrabec E, Strek M, Zieba M, Kwiatkowska S, Hrabec Z. Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis 2002;6:713-719.
23. Thurlbeck WM, Churg AM. Pathology of the lung. New York: Thieme Medical Publishers; 1995.
24. Okamoto T, Valacchi G, Gohil K, Akaike T, Van Der Vliet A. S-nitrosothiols inhibit cytokine-mediated induction of matrix metalloproteinase-9 in airway epithelial cells. Am J Respir Cell Mol Biol 2002;27:463-473.
25. Yao PM, Buhler JM, d'Ortho MP, Lebargy F, Delclaux C, Harf A, Lafuma C. Expression of matrix metalloproteinase gelatinases a and b by cultured epithelial cells from human bronchial expiants. J Biol Chem 1996;271:15580-15589.
26. Reunanen N, Westermarck J, Hakkinen L, Holmstrom TH, Elo I, Eriksson JE, Kahari VM. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem 1998;273:5137-5145.
27. Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (mmp)-1 and mmp-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol 2003;170:6244-6249.
28. Corcoran ML, Stetler-Stevenson WG, Brown PD, Wahl LM. Interleukin 4 inhibition of prostaglandin e2 synthesis blocks interstitial collagenase and 92-kda type iv collagenase/gelatinase production by human monocytes. J Biol Chem 1992;267:515-519.
29. Pillinger MH. Rosenthal PB, Tolani SN, Apsel B, Dinsell V, Greenberg J, Chan ES, Gomez PF, Abramson SB. Cyclooxygenase-2-derived e prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation. J Immunol 2003;171:6080-6089.
30. Vliagoftis H, Schwingshackl A, Milne CD, Duszyk M, Hollenberg MD, Wallace JL, Befus AD, Moqbel R. Proteinase-activated receptors-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol 2000;106:537-545.
31. Elkington PT, Green JA, Emerson JE, Lopez-Pascua LD, O'Kane CM, Friedland JS. Human airway epithelial cell matrix metalloproteinase-9 secretion in tuberculosis requires synergy between host and pathogen derived factors. 1st Joint Meeting of European National Societies of Immunology, Paris 2006;WC113:664.
32. Elkington PT, Green JA, Friedland JS. Filter sterilization of highly infectious samples to prevent false negative analysis of matrix metalloproteinase activity. J Immunol Methods 2006;309:115-119.
33. Leber TM, Balkwill FR. Zymography: a single-step staining method for quantitation of proteolytic activity on substrate gels. Anal Biochem 1997;249:24-28.
34. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type ii alveolar epithelial cells. Int J Cancer 1976;17:62-70.
35. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC. Cftr expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994;10:38-47.
36. Elkington PT, Emerson JE, Lopez-Pascua LD, O'Kane CM, Horncastle DE, Boyle JJ, Friedland JS. Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 mapk switch. J Immunol 2005;175:5333-5340.
37. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
38. Rivera-Marrero CA, Schuyler W, Roser S, Ritzenthaler JD, Newburn SA, Roman J. M. tuberculosis induction of matrix metalloproteinase-9: the role of mannose and receptor-mediated mechanisms. Am J Physiol Lung Cell Mol Physiol 2002;282:L546-L555.
39. Taylor JL, Hattle JM, Dreitz SA, Troudt JM, Izzo LS, Basaraba RJ, Orme IM, Matrisian LM, Izzo AA. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun 2006;74:6135-6144.
40. Izzo AA, Izzo LS, Kasimos J, Majka S. A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of mycobacterium tuberculosis pulmonary infection. Tuberculosis (Edinb) 2004;84:387-396.
41. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295:2387-2392.
42. Yao PM, Delclaux C, d'Ortho MP, Maitre B, Harf A, Lafuma C. Cell-matrix interactions modulate 92-kd gelatinase expression by human bronchial epithelial cells. Am J Respir Cell Mol Biol 1998;18:813-822.
43. Mercer BA, Kolesnikova N, Sonett J, D'Armiento J. Extracellular regulated kinase/mitogen activated protein kinase is up-regulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. J Biol Chem 2004;279:17690-17696.
44. Corcoran ML, Stetler-Stevenson WG, DeWitt DL, Wahl LM. Effect of cholera toxin and pertussis toxin on prostaglandin h synthase-2, prostaglandin e2, and matrix metalloproteinase production by human monocytes. Arch Biochem Biophys 1994;310:481-488.
45. Yao PM, Maitre B, Delacourt C, Buhler JM, Harf A, Lafuma C. Divergent regulation of 92-kda gelatinase and timp-1 by hbecs in response to il-lbeta and tnf-alpha. Am J Physiol 1997;273:L866-L874.
46. Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, Yokoyama M. Induction of mmp-9 in normal human bronchial epithelial cells by tnf-alpha via nf-kappa b-mediated pathway. Am J Physiol Lung Cell Mol Physiol 2001;281:L1444-L1452.
47. Lopez-Boado YS, Wilson CL, Parks WC. Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin. J Biol Chem 2001;276:41417-41423.
48. Elkington PT, Nuttall RK, Boyle JJ, O'Kane CM, Horncastle DE, Edwards DR, Friedland JS. Mycobacterium tuberculosis, but not vaccine beg, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med 2005;172:1596-1604.
49. Rothstein JL, Schreiber H. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA 1988;85:607-611.
50. Dannenberg AM Jr, Rook G. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses-dual mechanisms that control bacillary multiplication. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington: ASM; 1994. pp. 459-483.